ERBB2 and benign neoplasm: As shown in Fig. 3A, the expression of MAPK3 was significantly higher (P < 0.05) in HR + HER2− cancer tissue than in para-carcinoma tissue or benign tumor tissue when assessed by 5 or 3 multi-gene RG combinations.